Navigation Links
Telomere Biosciences Announces: TELO-20 for Dogs, the World's First Telomere-Lengthening Supplement for Dogs, to Promote Healthy Aging and Longevity

COLD SPRING, N.Y., Aug. 21, 2014 /PRNewswire/ -- Telomere Biosciences, LLC (Telomere Biosciences) announced today the launch of their Nutraceutical "TELO-20 for Dogs" with Telomerase Activation Complex, the first and only Telomere-lengthening supplement in the world for dogs. Telomeres are the protective caps at the ends of every chromosome in the body. A wealth of ground-breaking research by some of the world's leading experts in Telomere Science and Aging, including Nobel laureates, has demonstrated a strong connection between short Telomeres and many of the negative conditions associated with human aging, and also with canine aging.

"When we launched TELO-100 with T-Activator 150 in November 2013, we made our Mission clear," stated David B. Cross, founder of Telomere Biosciences: "To bring the breakthrough health benefits of Nobel prize-winning Telomere Science to a mass audience, applying the very latest research in the field to the most advanced Telomere Nutraceuticals available; and to make this leading-edge science price-accessible not only to the wealthy, but to all those who can benefit from longer Telomeres for a longer healthspan. We are excited and proud to say that TELO-20 for Dogs, at $49.95 for 60 chewable tablets that dogs love, now extends our Mission to the more than 70 million dogs in the U.S. alone, and almost all consider our pet dogs to be 'family members.'"

TELO-20 for Dogs is a proprietary 'complex' integrating 8 of the exact same natural ingredients as are in TELO-100 for humans. And while all 8 natural ingredients activate the Telomere-lengthening enzyme, Telomerase, all 8 go beyond just telomerase activation to also fight the other two major causes of Telomere shortening--Oxidative Stress and Inflammation--just as they uniquely do in TELO-100.

According to Cross, it is well known that Telomeres shorten as we age, but research shows that canine Telomeres actually shorten at a greatly accelerated rate in relation to humans--they 'age faster'--so TELO-20 for Dogs was specifically developed for all dogs ages 5-15+, just as TELO-100 was developed for all humans 40-90+. 

Cross added: "Telomere Biosciences is also committed to giving back, in this case to dogs in need, so from now through October 1, we are thrilled and humbled to donate $5 from every single bottle of TELO-20 for Dogs sold, to help Fresno Bully Rescue, , a non-profit, no-kill rescue and shelter dedicated to rescuing bully dog breeds, do their tremendous work."

Already TELO-20 for Dogs is garnering the attention of pet experts and dog owners: "I'm thrilled to have found a canine longevity product from a company that I trust," said Nikki Moustaki, award-winning author, dog trainer, and pet expert, in her recent review of TELO-20 on her website, "Because I take Telomere Biosciences' TELO-100 telomere product for humans, it's a no-brainer for me to give TELO-20 for Dogs to my furry pals on a daily basis. The science behind this product is convincing."

About Telomere Biosciences:
Telomere Biosciences, founded in 2010, is located at 10 North Street, Cold Spring, NY, and is privately held.                                                                

For more information on Telomere Biosciences, TELO-20 for Dogs and TELO-100 visit Facebook: TELO-20 for Dogs and Twitter: @Telo20forDogs 

Photo -   

SOURCE Telomere Biosciences, LLC
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Telomere Biosciences Announces: TELO-100 with T-Activator 150, a Breakthrough in Telomere Science and Age Management
2. Telomere Diagnostics, Inc. (TDx), previously known as Telome Health, Inc., announces its name change
3. Stem Cell and Telomere Support Provided by Stem Cell 100 from Life Code
4. Life Length Telomere Test Available Nationwide
5. Pressure BioSciences, Inc. Reports Second Quarter 2014 Financial Results and Provides Business Update
6. Leading ALS Researcher Joins the Kansas City University of Medicine and Biosciences
7. Regado Biosciences Announces Second Quarter 2014 Financial Results and Corporate Highlights
8. Sangamo BioSciences Announces Presentation At The 2014 Wedbush Securities Life Sciences Management Access Conference
9. Rancho BioSciences, in Partnership with Omicsoft, have Integrated Array Suite with tranSMART
10. Proove Biosciences Exhibits Industry Leading Data and Research at International Spine Intervention Society’s 22nd Annual Scientific Meeting
11. WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division
Post Your Comments:
(Date:11/24/2015)... , November 24, 2015 ... new market research report "Oligonucleotide Synthesis Market by Product ... (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical ... published by MarketsandMarkets, the market is expected to reach ... in 2015, at a CAGR of 10.1% during the ...
(Date:11/24/2015)... November 24, 2015 --> ... research report released by Transparency Market Research, the global ... a CAGR of 17.5% during the period between 2014 ... - Global Industry Analysis, Size, Volume, Share, Growth, Trends ... prenatal testing market to reach a valuation of US$2.38 ...
(Date:11/24/2015)... ... November 24, 2015 , ... In ... paramount. Insertion points for in-line sensors can represent a weak spot where leaking ... 781/784 series of retractable sensor housings , which are designed to tolerate extreme ...
(Date:11/24/2015)... , Nov. 24, 2015 Capricor Therapeutics, ... focused on the discovery, development and commercialization of first-in-class ... Chief Executive Officer, is scheduled to present at the ... at 10:50 a.m. EST, at The Lotte New York ... . . --> ...
Breaking Biology Technology:
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
(Date:10/29/2015)... Calif. , Oct. 29, 2015  The J. ... new report titled, "DNA Synthesis and Biosecurity: Lessons Learned ... the Department of Health and Human Services guidance for ... in 2010. --> ... it also has the potential to pose unique biosecurity ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):